C83.67 Undifferentiated (diffuse) non-Hodgkin's lymphoma, spleen

Name of the Condition

• Undifferentiated (diffuse) non-Hodgkin's lymphoma, spleen
• Also known as ICD-10 code C83.67

Summary

Undifferentiated (diffuse) non-Hodgkin's lymphoma is a subtype of non-Hodgkin lymphoma characterized by the malignant proliferation of lymphoid cells that lack distinct differentiation or follicular structure. It typically involves abnormal growth of B-cells or T-cells in lymph nodes or other lymphoid tissues, with a diffuse pattern of spread. This condition specifically affects the spleen and is part of the broader category of non-follicular lymphomas.

Causes

The exact cause of undifferentiated (diffuse) non-Hodgkin's lymphoma remains unknown. It is thought to involve genetic mutations or abnormalities in lymphoid cell development, though specific triggers are not well-defined. Research suggests potential links to immune system dysregulation or prior infections, but no definitive etiology has been established.

Risk Factors

• Age: More common in older adults.
• Family history of lymphoma.
• Prior exposure to radiation or certain chemicals.
• Chronic infections, such as hepatitis C or HIV.
• Immunosuppressive conditions or treatments.

Symptoms

• Enlarged spleen (splenomegaly).
• Abdominal discomfort or fullness.
• Unexplained weight loss.
• Fever.
• Night sweats.
• Fatigue.
• Loss of appetite.

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or MRI of the abdomen), and biopsy of the spleen or affected lymph nodes. Laboratory tests, including blood counts and possibly bone marrow biopsy, may also be performed to assess disease extent. Pathological analysis of tissue samples confirms the diagnosis by identifying undifferentiated lymphoid cells with a diffuse growth pattern.

Treatment Options

Treatment depends on the stage and aggressiveness of the lymphoma and may include chemotherapy, immunotherapy, or targeted therapy. In some cases, splenectomy (surgical removal of the spleen) may be considered, especially if the spleen is significantly enlarged or causing symptoms. Radiation therapy may be used for localized disease. Treatment plans are individualized based on the patient's overall health and specific subtype of lymphoma.

Prognosis and Follow-Up

Prognosis varies based on factors such as the lymphoma's subtype, stage at diagnosis, and response to treatment. Regular follow-up appointments, including physical exams and imaging, are essential to monitor for recurrence or progression. Long-term surveillance may be recommended, as some subtypes have a higher risk of relapse.

Complications

Potential complications include splenic rupture (rare but serious), infection due to impaired immune function, anemia or thrombocytopenia from bone marrow involvement, and organ damage from tumor growth or treatment side effects. Advanced disease may lead to systemic symptoms or involvement of other organs.

Lifestyle & Prevention

While prevention is not possible, maintaining a healthy lifestyle may support overall well-being during and after treatment. This includes balanced nutrition, regular exercise (as tolerated), and avoiding known risk factors like smoking or excessive alcohol use. Vaccinations (e.g., for influenza or pneumonia) may be recommended to reduce infection risk, especially if the immune system is compromised.

When to Seek Professional Help

Seek medical attention if you experience persistent abdominal pain, unexplained weight loss, fever, night sweats, or fatigue. Prompt evaluation is important if the spleen is enlarged or if symptoms worsen, as early diagnosis and treatment can improve outcomes.

Tips for Medical Coders

Code C83.67 is specific to undifferentiated (diffuse) non-Hodgkin's lymphoma involving the spleen. Ensure documentation clearly specifies the site (spleen) and confirms the diagnosis. Avoid using this code for lymphomas affecting other sites; instead, use the appropriate site-specific code. Verify that the diagnosis aligns with pathological findings and clinical presentation to support accurate coding.